The introduction of botulinum toxin more than 25 years ago for the management of
paediatric lower and upper limb hypertonia has been a major advance. BoNT-A as a part of …

Botulinum toxin A (BoNT-A) is considered a safe and effective therapy for children with
cerebral palsy (CP), especially in the hands of experienced injectors and for the majority of …

In this study, we reviewed the safety and efficacy of botulinum toxin type A (BoNT-A)
injection with respect to motor development in children with spastic cerebral palsy aged< 2 …

Management of children with cerebral palsy (CP) is the focus of considerable resources in
many countries, so that evaluation of the efficacy for new and established treatments is …

Cerebral palsy is the most common cause of spasticity and movement disorder in children.
Untreated spasticity leads to many complications, and therefore it is necessary to treat …

The treatment of children with cerebral palsy with Botulinum toxin A injections is well
established, safe and effective. However, a standardized injection strategy is still missing …

Botulinum toxin type A (BoNT-A) therapy has gained wide acceptance in the management of
spasticity in cerebral palsy (CP). Clinical experience from numerous case reports and series …

During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used
medical intervention in children with cerebral palsy. In this review we consider the gaps in …

Background The only two preparations of botulinum toxin A for which there are published
evidences of efficacy in children with cerebral palsy are onabotulinum toxin A (Botox®) and …

Objective: To evaluate whether botulinum toxin type A injections improve upper limb function
in children with cerebral palsy. Methods: An extensive search was carried out in PUBMED …